{"id":"NCT00569530","sponsor":"Roberta Ballard","briefTitle":"Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide","officialTitle":"Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2012-12","completion":"2012-12","firstPosted":"2007-12-07","resultsPosted":"2016-06-28","lastUpdate":"2021-05-11"},"enrollment":85,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction)","Bronchopulmonary Dysplasia"],"interventions":[{"type":"DRUG","name":"Infasurf (ONY Inc.)","otherNames":["Infasurf"]},{"type":"DRUG","name":"Sham","otherNames":["Air"]}],"arms":[{"label":"Treatment Surfactant (Infasurf) ONY, NY","type":"ACTIVE_COMPARATOR"},{"label":"Sham (no treatment)","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants.","primaryOutcome":{"measure":"SP-B Content","timeFrame":"One day after dose","effectByArm":[{"arm":"Treatment Surfactant (Infasurf) ONY, NY","deltaMin":19.9,"sd":null},{"arm":"Sham (no Treatment)","deltaMin":13.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"7 Days","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":9,"countries":["United States"]},"refs":{"pmids":["16870913","17671061","17403837","23037875"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":43},"commonTop":[]}}